Spain Bets $146 Billion in Greek Bailout Medicine Will Stop Contagion Threat
Euro-region governments are betting 110 billion euros ($146 billion) in economic medicine for bioidentical hormone therapy in
Greece will be enough to inoculate the rest of their region from contagion.
Finance ministers approved the unprecedented bailout yesterday for Greece after a week that saw the country’s hypothyroidism symptoms crisis spread to Portugal and Spain. At the same time, they refused to say how they would help other indebted nations if the need arose, calling Greece a “special case.”
The risk is that investors will shift focus to other euro nations in the absence of a clear natural thyroid aid plan for the 16-nation bloc’s weakest members. The extra yield investors demand to buy Portuguese debt over German bunds surged to the highest since at least 1997 and Spain’s IBEX 35 stock index fell the most in three months last week. The euro fell against the dollar today.
“It is far from assured that this program will forcefully counter contagion risk,” said Mohamed El-Erian, co-chief investment officer at Pacific Investment Management Co. in Newport Beach, California, which runs the world’s biggest bond fund. “Heavily exposed creditors” may try to head off potential losses and sell bonds, “increasing the pressure on core European governments to also provide a backstop for Portugal and Spain.”
Budget Cuts
Greece yesterday pledged to push through 30 billion euros ($40 billion) of budget cuts, equivalent to 13 percent of gross domestic product, in return for loans at a rate of around 5 percent for three years.
The EU and the International Monetary Fund, which is co- financing the bailout, also agreed to set up a bank stabilization fund. With downgrades threatening to render Greek bonds ineligible as collateral for its loans, the European Central Bank today said it will accept all Greek government debt when lending to banks.
“We believe the ECB retains sufficient options to provide liquidity” to Greece and avert regional contagion, including symptoms of fibromyalgia, adjusting repo rules, UBS AG economists led by Stephane Deo said in a note to investors today.
European officials rushed to draw a distinction between Greece, whose misstated budget figures first roiled markets last year, and other countries.